- Home
- PHM vs BNTX Comparison
PHM vs BNTX Comparison
Compare PHM & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHM
- BNTX
- Stock Information
- Founded
- PHM 1950
- BNTX 2008
- Country
- PHM United States
- BNTX Germany
- Employees
- PHM N/A
- BNTX N/A
- Industry
- PHM Homebuilding
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PHM Consumer Discretionary
- BNTX Health Care
- Exchange
- PHM Nasdaq
- BNTX Nasdaq
- Market Cap
- PHM 21.0B
- BNTX 25.0B
- IPO Year
- PHM N/A
- BNTX 2019
- Fundamental
- Price
- PHM $111.04
- BNTX $112.95
- Analyst Decision
- PHM Buy
- BNTX Strong Buy
- Analyst Count
- PHM 15
- BNTX 18
- Target Price
- PHM $132.57
- BNTX $141.55
- AVG Volume (30 Days)
- PHM 2.0M
- BNTX 730.8K
- Earning Date
- PHM 07-22-2025
- BNTX 08-04-2025
- Dividend Yield
- PHM 0.81%
- BNTX N/A
- EPS Growth
- PHM 13.61
- BNTX N/A
- EPS
- PHM 14.20
- BNTX N/A
- Revenue
- PHM $17,890,440,000.00
- BNTX $2,968,331,171.00
- Revenue This Year
- PHM N/A
- BNTX N/A
- Revenue Next Year
- PHM $2.46
- BNTX $10.68
- P/E Ratio
- PHM $7.67
- BNTX N/A
- Revenue Growth
- PHM 8.86
- BNTX 0.61
- 52 Week Low
- PHM $88.07
- BNTX $76.53
- 52 Week High
- PHM $149.47
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- PHM 63.72
- BNTX 65.06
- Support Level
- PHM $107.07
- BNTX $105.35
- Resistance Level
- PHM $112.18
- BNTX $111.82
- Average True Range (ATR)
- PHM 3.01
- BNTX 2.70
- MACD
- PHM 0.60
- BNTX 0.50
- Stochastic Oscillator
- PHM 91.37
- BNTX 98.40
About PHM PulteGroup Inc.
PulteGroup Inc is a homebuilder in the United States. The company mainly builds single-family detached homes and offers products to entry-level, move-up, and active-adult buyers. It also offers homebuyers mortgage financing, title, and insurance agency services through its financial services segment.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.